Clinical trials
Active, not recruiting Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
155 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 11 |
| 2018 | 8 |
| 2019 | 17 |
| 2020 | 17 |
| 2021 | 15 |
| 2022 | 22 |
| 2023 | 21 |
| 2024 | 9 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 155 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 15 |
| M.D. Anderson Cancer Center | 14 |
| Merck Sharp & Dohme LLC | 9 |
| AstraZeneca | 4 |
| Bristol-Myers Squibb | 3 |
| City of Hope Medical Center | 3 |
| Duke University | 3 |
| Exelixis | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 155 |
| Melanoma | 38 |
| Carcinoma, Non-Small-Cell Lung | 37 |
| Kidney Neoplasms | 29 |
| Squamous Cell Carcinoma of Head and Neck | 22 |
| Colorectal Neoplasms | 20 |
| Carcinoma, Transitional Cell | 17 |
| Ovarian Neoplasms | 17 |
| Neoplasm Metastasis | 14 |
| Stomach Neoplasms | 14 |
Trials
Showing 26 to 50 of 155. Each trial links to its page on Pharma Observatory.
55 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.